Markets:

Overview

News

Currencies

International

Treasuries

Charles River Laboratories International, Inc. Common Stock (NY:CRL)

199.48 UNCHANGED

Streaming Delayed Price Updated: 7:00 PM EST, Dec 31, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Charles River Laboratories International, Inc. Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

19 20 Next >

Charles River Laboratories’s (NYSE:CRL) Q3: Beats On Revenue

November 05, 2025

Lab services company Charles River Laboratories (NYSE:CRL) announced better-than-expected revenue in Q3 CY2025, but sales were flat year on year at $1.00 billion. Its non-GAAP profit of $2.43 per share...

Via StockStory

Charles River Laboratories Provides Update on Strategic Review

November 05, 2025

From Charles River Laboratories International, Inc.

Via Business Wire

Charles River Laboratories Announces Third-Quarter 2025 Results

November 05, 2025

From Charles River Laboratories International, Inc.

Via Business Wire

Earnings Scheduled For November 5, 2025 ↗

November 05, 2025

Via Benzinga

What To Expect From Charles River Laboratories’s (CRL) Q3 Earnings

November 03, 2025

Lab services company Charles River Laboratories (NYSE:CRL) will be announcing earnings results this Wednesday before market hours. Here’s what you need to know.

Via StockStory

Topics Artificial Intelligence

Charles River Laboratories Investigation Initiated By Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Charles River Laboratories International, Inc. - CRL

October 27, 2025

From Kahn Swick & Foti, LLC

Via Business Wire

Halper Sadeh LLC Encourages Charles River Laboratories International, Inc. Shareholders to Contact the Firm to Discuss Their Rights

October 24, 2025

From Halper Sadeh LLC

Via Business Wire

Charles River and the Francis Crick Institute Combine Expertise in Antibody-Drug Conjugate Development

October 22, 2025

From Charles River Laboratories International, Inc.

Via Business Wire

Charles River and X-Chem Announce Strategic Collaboration to Enhance Hit Identification Capabilities

October 20, 2025

From Charles River Laboratories International, Inc.

Via Business Wire

Discover which S&P500 stocks are making waves on Thursday. ↗

October 16, 2025

Stay updated with the movement of S&P500 stocks in today's session. Discover which S&P500 stocks are making waves on Thursday.

Via Chartmill

Charles River Announces Scientific Advisory Board to Drive Alternative Method Innovation and Adoption

October 15, 2025

From Charles River Laboratories International, Inc.

Via Business Wire

Charles River Laboratories Schedules Third-Quarter 2025 Earnings Release and Conference Call

October 14, 2025

From Charles River Laboratories International, Inc.

Via Business Wire

3 Reasons to Avoid CRL and 1 Stock to Buy Instead

October 14, 2025

The past six months have been a windfall for Charles River Laboratories’s shareholders. The company’s stock price has jumped 60.1%, hitting $170.64 per share. This was partly due to its solid quarterly...

Via StockStory

Winners And Losers Of Q2: Charles River Laboratories (NYSE:CRL) Vs The Rest Of The Drug Development Inputs & Services Stocks

October 08, 2025

Earnings results often indicate what direction a company will take in the months ahead. With Q2 behind us, let’s have a look at Charles River Laboratories (NYSE:CRL) and its peers.

Via StockStory

Charles River and Toxys Announce Collaboration to Validate the Use of NAMs for Developmental Toxicity Testing

October 08, 2025

From Charles River Laboratories International, Inc.

Via Business Wire

Why Charles River Stock May Struggle In Its Final Phase ↗

October 07, 2025

Adhishthana.com notes Charles River Stock is nearing its Phase 18, with momentum weakening and long-term outperformance looking unlikely.

Via Benzinga

Charles River Laboratories (CRL) Stock Is Up, What You Need To Know

October 03, 2025

Shares of lab services company Charles River Laboratories (NYSE:CRL) jumped 2.6% in the afternoon session after the stock's positive momentum continued, as Barclays upgraded the company to Overweight...

Via StockStory

What's going on in today's session: S&P500 movers ↗

October 02, 2025

Wondering what's happening in today's session for the S&P500 index? Stay informed with the top movers within the S&P500 index on Thursday.

Via Chartmill

Why Charles River Laboratories (CRL) Stock Is Up Today

October 02, 2025

Shares of lab services company Charles River Laboratories (NYSE:CRL) jumped 1.9% in the morning session after Barclays upgraded the company to Overweight from Equal-Weight and raised its price target.

Via StockStory

Topics Government

Wondering what's happening in today's S&P500 pre-market session? ↗

October 02, 2025

Before the US market kicks off on Thursday, let's examine the pre-market session and unveil the notable performers among the S&P500 top gainers and losers.

Via Chartmill

7 Analysts Assess Charles River: What You Need To Know ↗

October 02, 2025

Via Benzinga

Trump-Pfizer Deal Pushes Health Care Stocks To Best Rally In 5 Years ↗

October 01, 2025

Health care stocks rallied after Trump struck a drug pricing deal with Pfizer, offering major discounts and pausing pharma tariffs.

Via Benzinga

Topics Government

Wednesday's session: top gainers and losers in the S&P500 index ↗

October 01, 2025

Wondering what's happening in today's session for the S&P500 index? Stay informed with the top movers within the S&P500 index on Wednesday.

Via Chartmill

Which S&P500 stocks are moving on Wednesday? ↗

October 01, 2025

Let's delve into the developments on the US markets in the middle of the day on Wednesday. Below, you'll find the top gainers and losers within the S&P500 index during today's session.

Via Chartmill

Healthcare Sector Navigates Turbulent Waters as Drug Pricing Agreements Reshape Market Landscape

September 30, 2025

September 30, 2025 – The healthcare sector today finds itself at a pivotal juncture, experiencing a complex mix of optimism and apprehension. While a landmark drug-pricing agreement between...

Via MarketMinute

Topics Artificial Intelligence Economy Government

Masimo, Integra LifeSciences, CONMED, IQVIA, and Charles River Laboratories Shares Are Soaring, What You Need To Know

September 30, 2025

A number of stocks jumped in the afternoon session after reports revealed a potential drug-pricing agreement between the White House and the pharmaceutical industry. The Trump administration is...

Via StockStory

Topics Government World Trade

What's going on in today's session: S&P500 movers ↗

September 30, 2025

Stay informed about the performance of the S&P500 index one hour before the close of the markets on Tuesday. Uncover the top gainers and losers in today's session for valuable insights.

Via Chartmill

Mr Wonderful Kevin O'Leary Says Bitcoin, Ethereum Enough To 'Capture The Promise' Of Crypto, Advises Against 'Irrelevant' Tokens ↗

September 18, 2025

Renowned investor Kevin O’Leary expressed his belief on Wednesday that owning only Bitcoin (CRYPTO: BTC) and Ethereum (CRYPTO: ETH) can capture the majority of the cryptocurrency market’s volat

Via Benzinga

Charles River Laboratories Announces Chief Financial Officer Transition

September 16, 2025

From Charles River Laboratories International, Inc.

Via Business Wire

Uncover the latest developments among S&P500 stocks in today's session. ↗

September 12, 2025

Curious about the top performers within the S&P500 index one hour before the close of the markets on Friday? Dive into the list of today's session's top gainers and losers for a comprehensive...

Via Chartmill

< Previous 1 2 3 4 5 6 7 8 9

...

19 20 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.